RESUMO
DISCLOSURES: This introduction was written under the sponsorship of the PhRMA Foundation Award Program. The authors have nothing to disclose.
Assuntos
Prática Farmacêutica Baseada em Evidências/organização & administração , Conduta do Tratamento Medicamentoso/organização & administração , Medicina de Precisão , Distinções e Prêmios , FundaçõesRESUMO
The term comparative effectiveness research (CER) took center stage with passage of the American Recovery and Reinvestment Act (2009). The companion US$1.1 billion in funding prompted the launch of initiatives to train the scientific workforce capable of conducting and using CER. Passage of the Patient Protection and Affordable Care Act (2010) focused these initiatives on patients, coining the term 'patient-centered outcomes research' (PCOR). Educational and training initiatives were soon launched. This report describes the initiative of the Pharmaceutical Research and Manufacturers Association of America (PhRMA) Foundation. Through provision of grant funding to six academic Centers of Excellence, to spearheading and sponsoring three national conferences, the PhRMA Foundation has made significant contributions to creation of the scientific workforce that conducts and uses CER/PCOR.
